ARCHIVES

Low Prevalence Of Tamoxifen Use For Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 33 No. 2 | February 26, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Fredrickson Will Stay As NIH Director; NCI Group to Study Rhoads’ Clinical Center Idea

February 11, 1977

Cancer Letter Takes Two Weeks Off

August 28, 1987

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

NCI To Pilot Text Chat On CancerNet And CIS Sites.

September 29, 2000

CTI Files Appeal Over FDA’s Decision on Pixantrone

December 3, 2010

Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies.

July 9, 2010